Pages that link to "Q48672744"
Jump to navigation
Jump to search
The following pages link to Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide (Q48672744):
Displaying 32 items.
- PPAR-γ -- a possible drug target for complicated pregnancies (Q26863678) (← links)
- A protective role of ciglitazone in ox-LDL-induced rat microvascular endothelial cells via modulating PPARγ-dependent AMPK/eNOS pathway (Q34885372) (← links)
- Vitamin D receptor activation protects against myocardial reperfusion injury through inhibition of apoptosis and modulation of autophagy (Q35138227) (← links)
- Telmisartan activates endothelial nitric oxide synthase via Ser1177 phosphorylation in vascular endothelial cells (Q35168375) (← links)
- Cardiac NO signalling in the metabolic syndrome (Q35204828) (← links)
- Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injury (Q35789086) (← links)
- Rosiglitazone but not losartan prevents Nrf-2 dependent CD36 gene expression up-regulation in an in vivo atherosclerosis model (Q36494309) (← links)
- Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury (Q36774010) (← links)
- Roles of endothelial nitric oxide synthase (eNOS) and mitochondrial permeability transition pore (MPTP) in epoxyeicosatrienoic acid (EET)-induced cardioprotection against infarction in intact rat hearts (Q36824230) (← links)
- Mitochondrial nitroalkene formation and mild uncoupling in ischaemic preconditioning: implications for cardioprotection (Q37176170) (← links)
- PPARs as therapeutic targets in cardiovascular disease (Q37790384) (← links)
- PPAR-γ and AMPK – Advantageous targets for myocardial ischemia/reperfusion therapy (Q37871121) (← links)
- The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury (Q37926558) (← links)
- Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection. (Q38640842) (← links)
- PPARγ activator, rosiglitazone: Is it beneficial or harmful to the cardiovascular system? (Q39740098) (← links)
- Synergistic effects of atorvastatin and rosiglitazone on endothelium protection in rats with dyslipidemia (Q41779175) (← links)
- Protective Actions of PPAR-gamma Activation in Renal Endothelium (Q42008239) (← links)
- eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection? (Q42586952) (← links)
- Rosiglitazone inhibits high glucose-induced apoptosis in human umbilical vein endothelial cells through the PI3K/Akt/eNOS pathway (Q43273845) (← links)
- Intervention of rosiglitazone on myocardium Glut-4 mRNA expression during ischemia-reperfusion injury in cardio-pulmonary bypass in dogs (Q43498079) (← links)
- Activation of peroxisome-proliferator-activated receptors α and γ mediates remote ischemic preconditioning against myocardial infarction in vivo (Q43572274) (← links)
- Mechanisms responsible for beneficial and adverse effects of rosiglitazone in a rat model of acute cardiac ischaemia-reperfusion. (Q44797718) (← links)
- Peroxisome-proliferator-activated receptor γ mediates the second window of anaesthetic-induced preconditioning (Q45771801) (← links)
- The PPARγ agonist protects cardiomyocytes from oxidative stress and apoptosis via thioredoxin overexpression (Q46157450) (← links)
- Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice (Q46309781) (← links)
- Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats (Q46626429) (← links)
- Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide (Q46789134) (← links)
- Telmisartan attenuates myocardial apoptosis induced by chronic intermittent hypoxia in rats: modulation of nitric oxide metabolism and inflammatory mediators (Q46811876) (← links)
- Amelioration of anti-Thy1-glomerulonephritis by PPAR-gamma agonism without increase of endothelial progenitor cell homing (Q46852263) (← links)
- Effect of rosiglitazone on cardiac electrophysiology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart. (Q47372080) (← links)
- Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner (Q47388835) (← links)
- Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation (Q92241365) (← links)